Heme/Oncology III Flashcards
prednisone
bind intracytoplasmic - alter gene expression
MC glucocorticoid in cancer chemotherapy
adverse prednisone
cushing like syndrome
-weight gain, central obesity, muscle breakdown, cataract, acne, osteoporosis, HTN
bevacizumab
monoclonal Ab - VEGF
inhibit angiogenesis
erlotinib
EGFR tyrosine kinase inhibitor
tx - non small cell lung ca
adverse - rash
adverse bevacizumab
hemorrhage
VEGF mAb
imatinib
tyrosine kinase BCR-ABL inhibitor and c-kit inhibitor
clinical imatinib
CML - BCR-ABL
GI stromal tumor - c-kit
tyrosine kinase inhibitor
rituximab
monoclonal Ab - CD20 - B cell neoplasms
adverse rituximab
progressive multifocal leukencephalopathy
tamoxifen
selective estrogen receptor modulator - SERM
raloxifene
selective estrogen receptor modulator - SERM
SERM
selective estrogen receptor modulator
antagonist breast
agonist bone
tx breast cancer and prevent osteoporosis
tamoxifen
tamoxifen adverse
agonist endometrium - increased risk endometrial caner
raloxifene adverse
no increase in endometrial carcinoma
is estrogen receptor antagonist
trastuzumab
monoclonal Ab - Her-2 - tyrosine kinase receptor
tx of Her-2 positive breast cancer and gastric cancer
adverse trastuzumab
cardiotoxicity
vemurafenib
small molecule inhibitor BRAF oncogene
tx of melanoma
tx metastatic melanoma
vemurafenib
acoustic nerve damage
cisplatin
carboplatin
peripheral neuropathy
vincristine
pulmonary fibrosis
bleomycin
busulfan
cardiotoxicity
doxorubicin
trastuzumab
nephrotoxic
cisplatin
carboplatin
hemorrhagic cystitis
cyclophosphamide
myelosuppression
5-FU
6-MP
methotrexate
cell phase bleomycin
G2
cell phase paclitaxel
M
cell phase vinblastine
M
cell phase vincristine
M
cell phase cisplastin
G1
cell phase 5-FU
S
cell phase 6-MP
S
cell phase MTX
S
cell phase hydroxyurea
S